CCL20 and inflammatory bowel disease: In humans, CCR6 and/or MIP-3α/CCL20 have been implicated in the pathogenesis of rheumatoid arthritis and inflammatory bowel disease, autoimmune disorders in which Th17 cells are thought to play a crucial role [18,19].